Efficacy of adjunctive cenobamate by focal seizure subtypes: a randomized, double-blind, placebo-controlled, multicenter study in a multinational Asian population
作者
Xintong Wu,Ling Chen,Eun-Yeong Choe,Kyoung Heo,Seung Bong Hong,Koji Iida,Yong Heui Jeon,Julien Jung,Marc Kamin,Kensuke Kawai,Ji Hyun Kim,Myung Won Kim,Soon‐Tae Lee,Sunita N. Misra,Jungshin Park,William E. Rosenfeld,Tiancheng Wang,Takamichi Yamamoto,Peimin Yu,Louis Ferrari
Cenobamate reduced all focal seizure subtypes in a generally dose-response manner in adult Asian patients, including maintenance-phase seizure frequency reductions of 76 %-100 %. Notably high seizure-free rates were observed for patients with FBTC seizures, an important contributor to morbidity/mortality in focal epilepsy patients.